TS-161

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameTS-161
Drug Alias NameTS-161TP-0473292
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetabotropic glutamate receptor 2 antagonistsMetabotropic glutamate receptor 3 antagonists
TargetsMetabotropic glutamate receptor 3Metabotropic glutamate receptor 2
Therapy Area/IndicationsDepressive Disorder, Treatment-ResistantDepressive Disorder, MajorDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTaisho Pharmaceutical Holdings Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTaisho Pharmaceutical R&D IncNational Institute Of Mental Health (Nimh)Taisho Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, Treatment-ResistantDepressive Disorder, MajorDepression

Other Information

ATC CodeN/A
Related LinksN/A